Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
CureApp is a Tokyo-based digital therapeutics company that develops software-based prescription medical applications and related digital health platforms for clinical use. The company has created a pipeline of therapeutic smartphone apps and platforms targeting conditions including non-alcoholic steatohepatitis (NASH), hypertension, and nicotine dependence, and it advances those products through clinical trials. Founded in 2014, CureApp works with healthcare institutions and industry partners in Japan to generate clinical evidence and pursue regulatory approval and commercial deployment of its prescription digital therapies.